Evolving immunotherapeutic strategies in bladder and renal cancer.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 15192163.
- Also identified by PMC identifier 1743027.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
For patients with urological cancers, immunotherapy is currently a treatment option for metastatic renal cell carcinoma, and those with "high risk" superficial bladder cancers. In this review, our current understanding of tumour immune escape is discussed. The principles and role of current immunotherapies for these tumours are described, and new areas of immunotherapeutic promise are highlighted.
Medical subject headings
- Immunotherapy
- Kidney Neoplasms
- Urinary Bladder Neoplasms